Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins

Details for Australian Patent Application No. 2006269498 (hide)

Owner Kanisa Pharmaceuticals, Inc. Edgar, M.

Inventors Glenn, Scott; Schwegman, Jeff; Marcelletti, John; Hoth, Daniel; Walsh, Michael J.; Sikic, Branimir; Multani, Pratik S.; Socks, David

Agent Davies Collison Cave

Pub. Number AU-A-2006269498

PCT Pub. Number WO2007/008496

Priority 11/416,992 03.05.06 US; 60/696,756 06.07.05 US; 11/418,324 03.05.06 US; 11/416,832 03.05.06 US; 11/416,571 03.05.06 US; 11/418,400 03.05.06 US; 11/416,833 03.05.06 US; 11/416,829 03.05.06 US; 60/696,930 06.07.05 US; 60/696,939 06.07.05 US; 11/417,958 03.05.06 US

Filing date 30 June 2006

Wipo publication date 18 January 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/008496 Priority application(s): WO2007/008496

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006269501-Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism

2006269496-Maximized battery run-time in a parallel UPS system